ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 30 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,304,000 | +90.6% | 176,514 | 0.0% | 0.10% | +77.6% |
Q2 2016 | $1,209,000 | -23.5% | 176,514 | +5.6% | 0.06% | -24.7% |
Q1 2016 | $1,580,000 | -33.8% | 167,185 | -29.5% | 0.08% | -31.9% |
Q4 2015 | $2,387,000 | +57.0% | 237,070 | +123.2% | 0.11% | +43.0% |
Q3 2015 | $1,520,000 | – | 106,201 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |